Eterna Therapeutics Inc.

0.18
0.00 (1.12%)
At close: Apr 01, 2025, 3:54 PM
0.20
9.89%
After-hours: Apr 01, 2025, 07:57 PM EDT

Eterna Therapeutics Income Statement

Year FY24 FY23 FY22 FY21 FY20
Revenue 582K 68K n/a n/a n/a
Cost of Revenue 96K 236K 497K 459K 98K
Gross Profit 486K -168K -497K -459K -98K
Operating Income -15.67M -21.14M -33.22M 68.34M -7.25M
Interest Income 249K 138K n/a n/a n/a
Pretax Income -44.51M -21.67M -24.53M -122.3M -7.29M
Net Income -44.54M -21.67M -24.58M -122.31M 11.91M
Selling & General & Admin 13.13M 14.59M 16.84M 14.72M 3.3M
Research & Development 4.6M 5.92M 10.39M 12.71M 3.95M
Other Expenses -1.58M 461K -1.17M 899K n/a
Operating Expenses 16.16M 20.97M 27.23M 27.43M 7.25M
Interest Expense 6.75M 614K 30K 74K 43K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 16.26M 21.2M 27.23M 27.43M 7.25M
Income Tax 30K -3K 45K 5K -19.2M
Shares Outstanding (Basic) 13.65M 5.31M 3.05M 2.17M 439.7K
Shares Outstanding (Diluted) 13.65M 5.31M 3.05M 2.17M 439.7K
EPS (Basic) -3.26 -4.08 -8.06 -56.49 27.08
EPS (Diluted) n/a n/a n/a n/a n/a
EBITDA -36.12M -19.93M -33.22M -121.95M -7.15M
Depreciation & Amortization 1.64M 1.12M 497K 459K 98K